Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
D Ross CamidgeFabrice BarlesiJonathan Wade GoldmanDaniel MorgenszternRebecca S HeistEverett E VokesAlexander I SpiraEric AngevinWu-Chou SuDavid S HongJohn H StricklerMonica MotwaniMartin DunbarApurvasena ParikhElysa NoonVincent BlotJun WuKaren KellyPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
-M+, c-Met+ NSCLC.